A Study of Physical Activity in Cancer Survivors

Overview

About this study

The purpose of this study is to determine if to increasing physical activity (PA) will increase physical functioning, as measured by cardiovascular endurance, muscular strength, and balance in underserved adult cancer survivors of ages 18 or older residing at a rural address. Also, to deternube if increasing PA will increase quality of life (QOL), as measured by physical functioning and fatigue, in underserved cancer survivors ages 18 or older residing at a rural address.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* Adult, cancer survivors (no active disease) at Mayo Clinic Health System (MCHS) in Northwest Wisconsin (NWWI)
* Any stage cancer
* Age ≥60 years residing at any address, or ≥18 years residing at a rural address (as defined by Rural America, census.gov)
* Completed active treatment of surgery, (neo)adjuvant chemotherapy, and/or (neo) adjuvant radiation. Patients receiving adjuvant endocrine therapy, targeted therapy, or immunotherapy therapies are eligible.
* Ownership of a computer/tablet/smartphone with internet access.
* Willingness and ability to attend study visits.
* Must be able to complete semi-tandem (10 seconds), side-by-side tandem (10 seconds and SPPB Score of \>6 to qualify for virtual exercise.
* Must be ambulatory without the use of assisted device(s).

Exclusion Criteria:

* Receiving surgery, (neo)adjuvant chemotherapy, (neo) adjuvant radiation, palliative treatment
* Are already performing \>150 minutes/week of moderate activity or 75 min/week of vigorous physical activity
* Cancer-free for greater than 5 years
* Unable to complete weekly interventions/exercise due to traveling or unable to be active for more than 7 consecutive days.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/01/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Mankato, Minn. Mayo Clinic principal investigator Tamara OBrien, APRN, C.N.P., M.S.N.	Open for enrollment	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015
La Crosse, Wis. Mayo Clinic principal investigator Emily Stewart, P.A.-C., P.A.	Open for enrollment	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015
Eau Claire, Wis. Mayo Clinic principal investigator Kaye Sturz, APRN, C.N.P., D.N.P., M.S.	Open for enrollment	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015
Albert Lea, Minn. Mayo Clinic principal investigator Sydney Schone, APRN, C.N.P., D.N.P.	Open for enrollment	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015

Mayo Clinic Location

Status

Contact

Mankato, Minn.

Mayo Clinic principal investigator

Tamara OBrien, APRN, C.N.P., M.S.N.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

La Crosse, Wis.

Mayo Clinic principal investigator

Emily Stewart, P.A.-C., P.A.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Eau Claire, Wis.

Mayo Clinic principal investigator

Kaye Sturz, APRN, C.N.P., D.N.P., M.S.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Albert Lea, Minn.

Mayo Clinic principal investigator

Sydney Schone, APRN, C.N.P., D.N.P.

Open for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Clinical Trials